Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
Nakagawa T, Kami M, Hori A, Kim SW, Murashige N, Hamaki T, Kishi Y, Fujimoto H, Matsuoka N, Okajima E, Komiyama M, Tobisu K, Wakayama T, Uike N, Tajima K, Makimoto A, Mori S, Tanosaki R, Takaue Y, Kakizoe T.
Nakagawa T, et al. Among authors: okajima e.
Exp Hematol. 2004 Jul;32(7):599-606. doi: 10.1016/j.exphem.2004.04.006.
Exp Hematol. 2004.
PMID: 15246155
Free article.